HPV Vaccines Not As Effective For African-American Women04:25
Download

Play
This article is more than 5 years old.
One dose of the vaccine Gardasil, developed by Merck & Co. (Harry Cabluck/AP)
One dose of the vaccine Gardasil, developed by Merck & Co. (Harry Cabluck/AP)

The strains of the human papillomavirus (HPV) most common in African-American women are not targeted by the currently-available HPV vaccines.

A new study, funded by the National Cancer Institute, found that two subtypes of HPV used in current vaccines are half as likely to be found in African-American women than in white women.

The senior author of the study, Duke University professor Dr. Cathrine Hoyo, joins Here & Now's Robin Young with details.

Guest

  • Dr. Cathrine Hoyo, associate professor of obstetrics and gynecology at Duke University.

This segment aired on November 6, 2013.

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news